Bio-Rad releases first ce-ivd digital pcr test for monitoring chronic myeloid leukemia response to therapy
HERCULES, Calif. -- December 4, 2017 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announces the launch of the QXDx BCR-ABL %IS Kit, the...





